Vagal Stimulation Ameliorates Non-Alcoholic Fatty Liver Disease in Rats.

Hany A ElkattawySamar Mortada Mahmoud Ahmed El-Sayed HassanAhmed BehiryHasnaa Ali Ebrahim Ateya Megahed IbrahimDonia Elsaid Fathi ZaghamirMohamed El Sherbiny Sherein F El-Sayed

Published in: Biomedicines (2023)

Our findings suggest that VNS may represent a promising therapeutic candidate for managing NAFLD induced by obesity. It can be considered to be an effective adjuvant physiological intervention for the obese population with NAFLD to spare the liver against obesity-induced deleterious injury.

Keyphrases

weight loss
metabolic syndrome
insulin resistance
type diabetes
high fat diet induced
weight gain
randomized controlled trial
bariatric surgery
adipose tissue
high glucose
mouse model
drug induced
endothelial cells
physical activity
liver fibrosis